Skip to content

Second Canadian Trial of Physiologic Pacing (CTOPP II): Pilot Trial

Second Canadian Trial of Physiologic Pacing (CTOPP II): Pilot Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00182416
Enrollment
300
Registered
2005-09-16
Start date
2004-05-31
Completion date
2006-01-31
Last updated
2007-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pacemaker Dependence

Keywords

pacemakers, atrial fibrillation, stroke, cardiovascular death

Brief summary

Pacemaker therapy has been recognized as effective for the control of sinus and atrio-ventricular (AV) node dysfunction. Single chamber pacing when compared with dual chamber pacing, has numerous advantages of low complication rates, lower cost, better longevity, with non-inferiority in the quality of life and hard outcomes proven in direct randomized comparisons. However, comparison between single and dual chamber pacers was never adequate, since not more then half of the patients in the trials were actually using pacemakers for the majority of the time. Routine dual chamber pacing using a right ventricle apical lead is also associated with significant increase in peri-operative and remote complications. Some of these complications may be related to ventricular desynchronization secondary to the pacing location, which is potentially avoidable by using biventricular pacing. A randomized trial which will compare single chamber rate responsive pacing to the best available modification of dual chamber pacing (biventricular pacing) in suitable patients is therefore warranted.

Interventions

DEVICEpacemaker

Sponsors

Medtronic
CollaboratorINDUSTRY
Sunnybrook Health Sciences Centre
CollaboratorOTHER
Hamilton Health Sciences Corporation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
66 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient has symptomatic bradycardia and is a candidate for first pacemaker implantation * Patient has high risk of being pacemaker dependent by (at least one of the following): 1. Average heart rate of 60 or less on pre-implant Holter 2. Maximal heart rate of 60 in patient on telemetry monitoring 12 hrs preoperatively, when not under medications decreasing heart rate, or under chronic medical treatment inducing bradycardia, which is unlikely to be changed 3. First degree AV block with PR intervals \> 300 ms, or second degree AV block at heart rates \<= 80 bpm. 4. Dependence for 12 hrs when on temporary pacemaker set at 50 bpm if bradycardia is not secondary to medication, or under chronic medical treatment inducing bradycardia, which is unlikely to be changed.

Exclusion criteria

* Age \<= 65 years * Chronic Atrial Fibrillation * Indication for ICD * Non-cardiovascular death is likely to occur within 3 years * Geographical, social, or psychiatric reasons making follow-up problematic

Design outcomes

Primary

MeasureTime frame
Predictors of future pacemaker dependence
Feasibility of the trial

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026